eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hartnup disease |
| Comorbidity | C0001206|acromegaly |
| Sentences | 2 |
| PubMedID- 20012914 | This assesses the strength of evidence supporting the assertion that a gh of ≤1.0 μg/l as a random measurement or as a nadir after an ogtt correlates with disease control in patients with acromegaly and, therefore, should be a goal of therapy. |
| PubMedID- 21597975 | Table 4 highlights cardiac function endpoints from one study as an example of what might be achieved with disease control in patients with acromegaly [29]. |
Page: 1